Market News & Trends
Lupin Acquires Nanomi, Heading Toward Complex Injectables Space
Pharmaceutical major Lupin Limited recently announced the acquisition of Nanomi B.V. in the Netherlands. With this acquisition, Lupin has made its foray into the technology…
A Silk Coat for Diamonds Makes Sleek New Imaging and Drug Delivery Tool
Silk and diamonds aren't just for ties and jewelry anymore. They're ingredients for a new kind of tiny glowing particle that could provide doctors and…
Novozymes Biopharma Announces New Data Highlighting Potential for Monthly Drug Dosing
Novozymes Biopharma recently announced new data on extending the serum half-life of albumin in vivo. This compelling data set, recently presented at PepTalk 2014, demonstrates…
Strong Pipeline of Monoclonal Antibodies Biosimilars in the US & Europe Lends Impetus to Global Market
The imminent entry of several companies, including big pharma, small biotech, and generic participants, into the global biosimilars space will propel the market toward exponential…
Gerresheimer Develops Interface for Integrating Glass Syringes in Autoinjectors
The development of autoinjectors generally involves the integration of a prefilled glass syringe into a plastic drug delivery device - a major challenge due to…
Horizon Discovery Signs Large-Scale License Agreement
Horizon Discovery recently announced it has entered into a large-scale licensing agreement with a Japanese medical university. The agreement covers a limited use label license…
Promising New Therapies to Boost Global Hepatitis C Market by 2019
Due to a large untreated patient pool and the recent approval of new treatments, the hepatitis C market will more than treble from $5.7 billion…
Automated Anatomic Pathology Labs Transform Global Tissue Diagnostics Market
Growth in diagnostic test volume conducted across hospitals worldwide is lending momentum to the global tissue diagnostics market. In addition, the shortage of pathologists to…
Gateway Analytical Acquires RapID System to Meet Growing Market Demand
Gateway Analytical recently announced they have acquired the RapID SPE-ls raman.ID + metal.ID system, the latest technology in automated particle identification. This acquisition enhances existing…
Alexza Pharmaceuticals Announces $1-Million Milestone Payment
Alexza Pharmaceuticals, Inc. recently announced that ADASUVE inhalation powder, predispensed (Staccato loxapine) is now available in Spain through Grupo Ferrer Internacional, S.A. (Ferrer). Ferrer is…
Bladder Cancer Market to Witness Moderate Growth by 2017
The bladder cancer therapeutics market in the six major countries (6MM) - the US, France, Germany, Italy, Spain, and UK - is forecast to climb…
Biocon Collaborates With Advaxis
Biocon Ltd. and Advaxis, Inc. recently announced they have entered into an exclusive licensing agreement for co-development and commercialization of ADXS-HPV, a novel cancer immunotherapy…
Alitair Announces Issuance of Third Patent for its Drug Delivery Platform
Alitair Pharmaceuticals, Inc. recently announced the issuance of US Patent No. 8,617,602 from theUSPTO for its ion exchange resin drug delivery technology, REA. "Our…
Bristol-Myers Seeks Innovative Drugs
Bristol-Myers Squibb Co. will continue to seek out innovative drugs to buy, particularly for cancer, shrugging off two previous deals totaling $7.8 billion in the…
Valeant, Actavis, Mylan Pursue Pfizer's Generics Unit
Drugmakers Valeant Pharmaceuticals International Inc., Actavis Plc, and Mylan Inc. have all expressed interest in buying Pfizer Inc's branded generics business, but no active discussions…
Moderna Launches Spin-Off for mRNA-Based Cancer Drugs
With a $110-million financing round and big-time deals with AstraZeneca and Alexion Pharmaceuticals in the bag, biotech company Moderna Therapeutics’ next big move is to…
Monoclonal Antibodies Market for Gastric & Esophageal Cancers to Double by 2019
Due to favorable market conditions in terms of US pricing structures and the anticipated approval of a number of late-stage pipeline drugs, the market value…
Isis Pharmaceuticals, Inc. to Receive $7.5 Million From Alnylam
Isis Pharmaceuticals, Inc. recently announced it will receive $7.5 million from Alnylam Pharmaceuticals, Inc. from the recently announced alliance between Genzyme and Alnylam. In addition,…
NantBioScience Announces Strategic Collaboration With Celgene
NantBioScience recently announced a strategic collaboration with Celgene to advance bold research programs to benefit cancer patients in need of new therapeutic solutions. As part…
Marina Biotech Strengthens IP Estate for SMARTICLES Nucleic Acid Delivery Technology
Marina Biotech, Inc. recently announced the grant and issuance of patents relating to the company's proprietary nucleic-acid delivery technology, SMARTICLES. The US Patent and Trademark…
